Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Pituitary tumor
Trial Type:  Treatment
Results 1-6 of 6 for your search:
Start Over
Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Status: Active
Phase: Phase III
Type: Treatment
Age: 18 to 75
Trial IDs: CLCI699C2301, NCI-2017-00022, 2013-004766-34, NCT02180217
Surgery or Observation in Treating Patients with Adrenal Tumors Associated with High Levels of Cortisol
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 14-C-0021, NCI-2014-02499, P131265, 140021, NCT02001051
Long-Acting Release Pasireotide in Treating Patients with ACTH-Producing Pituitary Gland Tumors
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 to 80
Trial IDs: AAAQ6255, NCI-2016-01084, NCT02749227
Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: S1609, NCI-2016-01041, NCT02834013
OTL38 in Imaging Patients with Suspected Pituitary Adenoma Undergoing Surgery
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Age: 18 and over
Trial IDs: UPCC 18315, NCI-2015-01600, 822782, NCT02769533
Mifepristone in Treating Patients With Cancer
Status: Enrolling by invitation
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: INST 0817, NCI-2011-02682, NCT00832871
Start Over